Versuchen GOLD - Frei
How Ozempic ate away the plus-size movement
Mint Mumbai
|October 07, 2025
A body-neutral fat activist reflects on how weight-loss drugs have erased the hard-won gains of the body neutrality campaign
My Instagram feed is very curated, so [rarely see things I don’t want to. Even though I'ma fat 43-year old single woman, I don’t see weight loss, work out, or dating ads. So it took a while for the Serena Williams Ozempic ad to cross my path, and it did ina shocked reaction from one of the fat activists I follow. Curious, I looked it up.
I was expecting to be enraged, but my first reaction was bone deep sorrow, because here is possibly the greatest athlete alive, saying that, even though she won 23 grand slams and has Olympic gold medals, even though she is adored and admired for her very apparent success, it was incomplete because her body wasn’t small enough.
As a body-neutral fat activist, I think everyone is allowed to want the body they want and do what they want to get it. But as a human, it breaks my heart that what Serena is wasn’t enough, and she felt she had to do this. Maybe she had medical or sports reasons for needing that weight loss. Maybe she is, like most women, deeply stressed by the way her body changes as it goes through life and age. Yes, I am deeply disappointed that a Black feminist icon now stands for a message that will almost certainly destroy the mental and physical health of many people, mostly women and girls.
But the thing that really causes the deep grief I am feeling is that the world has, so quickly, turned away from the beautiful cause of fat liberation.
Diese Geschichte stammt aus der October 07, 2025-Ausgabe von Mint Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Mumbai
Mint Mumbai
Europe bets on $25 bn space budget amid defence hike
Europe’s equivalent of NASA is seeking €22 billion ($25.
1 min
November 27, 2025
Mint Mumbai
China’s ‘McNuggetization’: It’s beneficial for the environment
A wide-scope dietary shift in China is doing the planet a good turn
3 mins
November 27, 2025
Mint Mumbai
Flexi-cap funds in focus as smids falter
A silent pivot
3 mins
November 27, 2025
Mint Mumbai
Labour codes: Focus on empathy and not just efficiency
The consolidation of 29 archaic labour laws into four comprehensive new codes—on wages, social security, industrial relations and occupational safety—is among the most significant structural reforms undertaken by India in the post-liberalization era.
3 mins
November 27, 2025
Mint Mumbai
These firms will sell shovels during semaglutide gold rush
Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.
2 mins
November 27, 2025
Mint Mumbai
HC to hear Apple's plea on fine in Dec
Apple is challenging the new penalty math formula in India's competition law.
1 min
November 27, 2025
Mint Mumbai
Climate crisis: Innovation works, compression doesn't
After weeks of hot air, the UN’s CoP summit limped to an end in Brazil's Amazonian hub of Belém over the weekend, with a ‘deal’ that delivers nothing measurable for the climate, while wasting political capital and much effort on pledges.
3 mins
November 27, 2025
Mint Mumbai
MO Alternates launches its maiden private credit fund
The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions
3 mins
November 27, 2025
Mint Mumbai
Kharif grain production likely to rise to 173 mt
India's kharif foodgrain output is expected to rise to 173.
1 min
November 27, 2025
Mint Mumbai
IL&FS group repays ₹48,463 cr loan
Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.
1 min
November 27, 2025
Listen
Translate
Change font size

